Genetics and biochemistry are two closely related scientific fields. Genetics is the study of heredity, the transmission of physical traits from parent to offspring, and how those traits are affected by the environment. Biochemistry is the study of the structure and function of biological molecules, such as proteins, nucleic acids, and carbohydrates, and how they interact with each other and with the environment. Genetics and biochemistry are intricately linked, as changes in an organism’s genetic material (known as mutations) can cause changes to its biochemistry and, in turn, to its physical traits. For instance, a change to the sequence of an organism's genes may affect the production or activity of proteins, which in turn could affect the organism's physical appearance. Similarly, differences in the structure of a protein-coding gene may lead to different variants of the same protein, which may produce different results in the body. By studying how genetics and biochemistry interact, scientists can gain insight into the causes of diseases and the development of treatments for them. For instance, understanding how a particular gene mutation or alteration in biochemistry may lead to a medical condition can help scientists develop ways to prevent or treat it. In addition, understanding how certain proteins interact to form networks within cells can provide further insight into how diseases develop and how they can be treated. In the end, both genetics and biochemistry offer valuable insights into how living organisms work and how they interact with their environment. Together, they are powerful tools for developing new treatments for diseases and improving our understanding of the natural world.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States